Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-27

Clinical Trial Update: Berberine in Treating Negative Symptoms of Schizophrenia: Clinical Efficacy and Mechanisms [NA]

View source ↗

Summary

Berberine is being studied for negative symptoms of schizophrenia, with the trial currently enrolling by invitation and no phase specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Berberine (berberine)

Snippet

Sponsor: Tianjin Anding Hospital | Conditions: Schizophrenia, Negative Symptoms of Schizophrenia | NA | Status: ENROLLING_BY_INVITATION